Spontaneous and indicated preterm delivery in pregestational diabetes mellitus: etiology and risk factors

Archives of Gynecology and Obstetrics
Nir MelamedYariv Yogev

Abstract

To characterize the indications for preterm delivery and identify risk factors predicting preterm delivery in pregnancies complicated by pregestational diabetes (PGDM). A retrospective cohort study of all women with type 1 or type 2 diabetes mellitus followed from preconception to delivery at our institute from 1996 to 2004 (study group). Rates of spontaneous and indicated preterm delivery were compared with a control group of nondiabetic women. Rates of preterm delivery were 26.6% (119/448) and 6.0% (1,038/17,370) in the study and control groups, respectively (P < 0.001). The PGDM group had higher rates of both spontaneous (6.9% vs. 4.8%, P < 0.001) and indicated (19.6% vs. 1.2%, P < 0.001) preterm deliveries. Most of the preterm deliveries in the PGDM group were indicated (73.9%) compared with 20.1% in the control group (P < 0.001). Preeclampsia was the most significant factor associated with indicated preterm delivery in the PGDM group (OR = 11.7, 95% CI = 3.3-41.7), followed by nephropathy, nulliparity, HbA1c levels prior to conception and prior to delivery, duration of diabetes, prepregnancy body mass index and weight gain during pregnancy. Spontaneous preterm delivery was related to duration of diabetes, presence of nephr...Continue Reading

References

Feb 13, 1991·JAMA : the Journal of the American Medical Association·J L KitzmillerW D Zigrang
Jul 1, 1989·American Journal of Obstetrics and Gynecology·M F GreeneJ E Scherl
Oct 1, 1993·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·B RosennT A Siddiqi
Apr 1, 1996·American Journal of Obstetrics and Gynecology
Mar 1, 1996·Obstetrics and Gynecology Clinics of North America·J L Kitzmiller, C A Combs
Jun 1, 1997·European Journal of Obstetrics, Gynecology, and Reproductive Biology·I Bar-HavaM Y Divon
Jun 28, 2000·The Australian & New Zealand Journal of Obstetrics & Gynaecology·J E GuntonE Wilmshurst
Sep 28, 2001·Diabetes Care·P EkbomE R Mathiesen
Oct 12, 2002·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·O KovilamB Sibai
Oct 28, 2003·Diabetes Care·Pierre BoulotUNKNOWN Diabetes and Pregnancy Group, France
Nov 25, 2004·Diabetes Care·Dorte M JensenHenning Beck-Nielsen
Sep 6, 2005·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Finn F LauszusJoachim G Klebe
Jul 29, 2006·Diabetes Care·Rosemary C TempleHelen R Murphy
Sep 2, 2006·Obstetrics and Gynecology·Joanne YangKrista Jangaard

❮ Previous
Next ❯

Citations

Jun 17, 2011·Antioxidants & Redox Signaling·Martha LappasAlicia Jawerbaum
Nov 26, 2010·International Journal of Epidemiology·Zhen HanUNKNOWN Knowledge Synthesis Group
Jul 22, 2010·BMJ : British Medical Journal·Sarah D McDonaldUNKNOWN Knowledge Synthesis Group
Jun 6, 2012·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·H MirghaniF Khan
Jun 1, 2011·Acta Obstetricia Et Gynecologica Scandinavica·Zhen HanUNKNOWN Knowledge Synthesis Group
Jan 22, 2009·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Nir Melamed, Moshe Hod
Dec 24, 2013·American Journal of Obstetrics and Gynecology·Nansi S BoghossianCuilin Zhang
Oct 8, 2009·The Journal of Clinical Endocrinology and Metabolism·Montserrat BalsellsR Corcoy
Aug 22, 2018·BMC Pregnancy and Childbirth·Emily W HarvilleLydia A Bazzano
Dec 22, 2020·American Journal of Obstetrics & Gynecology MFM·Beverly C TseRuofan Yao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.